Targeting SEZ6L2 in Colon Cancer: Efficacy of Bexarotene and Implications for Survival
Crossref DOI link: https://doi.org/10.1007/s12029-024-01085-9
Published Online: 2024-07-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zheng, Huajun
Zheng, Jianying
Shen, Yan
Text and Data Mining valid from 2024-07-02
Version of Record valid from 2024-07-02
Article History
Accepted: 19 June 2024
First Online: 2 July 2024
Declarations
:
: The authors declare no competing interests.